dextroamphetamine has been researched along with Condition, Preneoplastic in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Miglio, MR | 1 |
| Muroni, MR | 1 |
| Simile, MM | 1 |
| Calvisi, DF | 1 |
| Tolu, P | 1 |
| Deiana, L | 1 |
| Carru, A | 1 |
| Bonelli, G | 1 |
| Feo, F | 1 |
| Pascale, RM | 1 |
1 other study available for dextroamphetamine and Condition, Preneoplastic
| Article | Year |
|---|---|
Implication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Coloring Agents; Dextroamphetamine; Diethylnitrosami | 2000 |